• Citer

Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.

par Tabernero, Josep;Van Cutsem, Eric;Díaz-Rubio, Eduardo;Cervantes, Andrés;Humblet, Yves;André, Thierry;Van Laethem, Jean-Luc ;Soulié, Patrick;Casado, Esther;Verslype, Chris;Valera, Javier Sastre;Tortora, Giampaolo;Ciardiello, Fortunato;Kisker, Oliver;de Gramont, Aimery
Référence Journal of clinical oncology, 25, 33, page (5225-5232)
Publication Publié, 2007-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer.
Auteur:	Tabernero, Josep; Van Cutsem, Eric; Díaz-Rubio, Eduardo; Cervantes, Andrés; Humblet, Yves; André, Thierry; Van Laethem, Jean-Luc; Soulié, Patrick; Casado, Esther; Verslype, Chris; Valera, Javier Sastre; Tortora, Giampaolo; Ciardiello, Fortunato; Kisker, Oliver; de Gramont, Aimery
Informations sur la publication:	Journal of clinical oncology, 25, 33, page (5225-5232)
Statut de publication:	Publié, 2007-11
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Animals
	Antibodies, Monoclonal -- administration & dosage -- adverse effects
	Antineoplastic Combined Chemotherapy Protocols -- administration & dosage -- adverse effects -- therapeutic use
	Colorectal Neoplasms -- drug therapy
	Female
	Fluorouracil -- administration & dosage
	Humans
	Leucovorin -- administration & dosage
	Male
	Mice
	Mice, Inbred BALB C
	Middle Aged
	Neoplasm Metastasis
	Neoplasm Transplantation
	Organoplatinum Compounds -- administration & dosage
	Patient Compliance
	Transplantation, Heterologous
Note générale:	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2007.13.2183
	info:pii/25/33/5225
	info:pmid/18024868